A detailed history of Allworth Financial LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Allworth Financial LP holds 120 shares of DVAX stock, worth $1,539. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Previous 152 21.05%
Holding current value
$1,539
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$10.05 - $11.61 $321 - $371
-32 Reduced 21.05%
120 $1,000
Q2 2024

Jul 23, 2024

BUY
$10.73 - $12.58 $493 - $578
46 Added 43.4%
152 $1,000
Q2 2023

Jul 18, 2023

BUY
$9.85 - $13.17 $157 - $210
16 Added 17.78%
106 $1,000
Q1 2023

Apr 18, 2023

BUY
$9.44 - $11.88 $660 - $831
70 Added 350.0%
90 $0
Q3 2022

Oct 18, 2022

BUY
$9.93 - $17.44 $198 - $348
20 New
20 $0
Q4 2021

Jan 21, 2022

SELL
$13.17 - $20.94 $1,317 - $2,094
-100 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$9.16 - $19.83 $916 - $1,982
100 New
100 $2,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.